Pioneering Superspecialty quality healthcare in North East India, as ever, Health city Hospitals, super specialty healthcare centre in North East India, today organized a press meet. The Press meet was graced by Professor Katsumi Takizawa, Department of Neurosurgery, Japanese Red Cross Hospital, Asahikawa, Japan and Dr. N.K.Das Director Neurosurgery , Health City Hospital. The Press meet enhanced participants’ knowledge about prognosis, diagnosis and treatment of Moyamoya. Speaking on the occasion, Dr. N.K.Das Director Neurosurgery , Health City Hospital said, “On behalf of all doctors in the event, I would like to express our heartfelt gratitude to Professor Katsumi Takizawa. The region is experiencing the debilitating burden of non-communicable disease due to environmental and changing lifestyle factors. Incidences of diseases like Moyamoya are often untreated due to inadequate awareness about the disease, its causes and symptoms. This Press meet would help us provide quality healthcare for Moyamoya in the North East region. As medical professionals, we need continuous information about the recent developments in the field of medical science, not only to educate ourselves but also to keep abreast of the latest trends which translate into better patient care.”
Moyamoya disease – caused by blocked arteries at the base of the brain – affects both children and adults. First detected in Japan, this condition also often afflicts members of the population in North East India, due to genetic ties. The condition is responsible for 0.1-9 % stroke among the population in the North East India. Moyamoya is a progressive, occlusive disease of the cerebral vasculature, with particular involvement of the circle of Willis and the arteries that feed it. The name “Moyamoya” means “puff of smoke” in Japanese and describes the visual appearance of the tangle of tiny vessels formed to compensate for the blockage.
On the occasion, Prof. Takizawa elucidated that in Japan, Moyamoya disease normally occurs in females under the age of 20. In Japan, the disease is estimated to occur in 1 per 1 million people. Although Moyamoya was originally reported in individuals of Japanese ancestry, cases have been reported from elsewhere in Asia as well as from Europe, North and South America, and most cases reported in the western hemisphere have been patients of Asian descent. People living in North East India are vulnerable to the disease due to the genetic connections. Creating more awareness is essential for securing the health of the victim in early stages.”9 years old child was diagnosed with Moyamoya disease outside has been operated successfully on 20/02/23 at Health City Hospital Yesterday. The operation was successfully done by Dr N K Das and his team. Professor Katsumi Takizawa was also in the Operation as an observer.
